Latest News & Features
Americas
AbbVie has again urged the US Supreme Court to save it from claims of filing sham litigation to block competition for testosterone treatment AndroGel. 3 June 2021
Big Pharma
The US Court of Appeals for the Federal Circuit has upheld a decision from the US International Trade Commission that found 10X Genomics infringed on two Bio-Rad Laboratories gene sequencing patents. 3 June 2021
Europe
Munich-based firm Bardehle Pagenberg has established a life sciences practice at its Paris office with two recent hires. 1 June 2021
Biotechnology
A CRISPR patent filed by scientist Emmanuelle Charpentier alongside the Regents of the University of California and the University of Vienna has been upheld by the Japan Patent Office. 1 June 2021
Americas
A non-fungible token for a Nobel Prize-winning cancer immunotherapy invention has been minted ahead of an auction tomorrow arranged by the University of California, Berkeley. 1 June 2021
Big Pharma
President Xi Jingping has announced his support for waiving IP rights for COVID-19 vaccines. 1 June 2021
Americas
Philips has settled trade secrets and copyright claims against a medical imaging company, having already survived accusations of breaching antitrust law. 27 May 2021
Americas
AbbVie and its exclusive licensee have settled a patent lawsuit against Taro Pharmaceutical over a generic rosacea drug. 27 May 2021
article
Skinny labelling has long allowed generic drugs to be approved for non-patented indications, allowing them to enter the market before the brand-name drug’s patent for other indications expires. In the recent GSK v Teva lawsuits, skinny labelling did not protect Teva from patent infringement and $235 million in damages. 27 May 2021
Big Pharma
Illumina and Roche-owned Ariosa Diagnostics filed a joint stipulation asking the US Supreme Court to dismiss a case concerning the eligibility of Illumina’s DNA testing patents. 27 May 2021